期刊文献+

Ⅰ型神经纤维瘤病中血管病变的研究进展 被引量:2

Research Progress of Vascular Abnormalities in NF1
下载PDF
导出
摘要 Ⅰ型神经纤维瘤病是一种常见的常染色体显性遗传病,主要由NF1基因突变导致。临床表现包括皮肤色斑和良性神经纤维瘤,病变可累及神经、骨骼、血管等多种组织结构。血管病变是NF1的常见并发症,患病率和死亡率较高。本文针对NF1中血管性病变的研究进展进行综述。 Neurofibromatosis type 1 is a common autosomal dominant condition caused by heterozygous mutations of the NF1 gene. The most frequent clinical manifestations are alterations of skin pigmentation and benign neurofibromas, but patients with NF1 may also develop nervous system tumors, skeletal abnormalities, or vascular disease. Vascular abnormalities is a common complication of NF1 and may lead to a high morbidity and mortality. The new findings of vascular abnormalities NF1were reviewed in this paper.
出处 《组织工程与重建外科杂志》 2014年第4期218-221,共4页 Journal of Tissue Engineering and Reconstructive Surgery
关键词 Ⅰ型神经纤维瘤病 血管病变 机制 病理 治疗 Neurofibromatosis type 1 Vascular abnormalities Pathogenesis Pathology Therapy
  • 相关文献

参考文献3

二级参考文献526

  • 1DeVeber G. In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines. Lancet Neurol, 2005, 4:432 - 436.
  • 2Michenfelder JD, Milde JH. The relationship among canine brain temperature, metabolism, and function dtring hypothermia. Anesthesiology, 1991, 75:130 - 136.
  • 3Takagi K. Body temperature in acute stroke. Stroke, 2002, 33:2154 - 2155.
  • 4Schwab S, Georgiadis D, Berrouschot J, et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke, 2001,32:2033 -2035.
  • 5Gupta R, Jovin TG, Krieger DW. Therapeutic hypothermia for stroke: do new outfits change an old friend? Expert Rev Neurother, 2005, 5: 235 - 246.
  • 6Massicotte P, Adams M, Marzinotto V, et al. Lowmolecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr, 1996, 128:313 -318.
  • 7Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatr Neurol, 2003, 29:295 -298.
  • 8Strater R, Kurnik K, Heller C, et al. Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke, 2001,32:2554 -2558.
  • 9Cheung YF, Leung MP. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease. J Paediatr Child Health, 2003, 34: 563 - 567.
  • 10Ruud E, Holmstrom H, De Lange C, et al. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies-a randomized, controlled study. Acta Paediatr, 2006, 95 : 1053 - 1059.

共引文献79

同被引文献17

  • 1赵霞,周列民,周珏倩,梁秀龄,操德智,李伟峰,陈子怡.Ⅰ型神经纤维瘤病患者神经纤维瘤发生机制的研究[J].中山大学学报(医学科学版),2005,26(6):680-683. 被引量:3
  • 2王金龙,凌锋,吉训明,宋庆斌,黄居义,王玉林.DSA在脑静脉窦血栓形成介入检查和治疗中的应用[J].中国医学计算机成像杂志,2006,12(1):49-51. 被引量:9
  • 3吴江.神经病学[M].北京:人民卫生出版社,2010:283.
  • 4程芙蓉,周列民.1型神经纤维瘤病发病机制的研究进展[J].国际内科学杂志,2007,34(9):514-517. 被引量:5
  • 5Lin AL,Gutmann DH.Advances in the treatment of neurofibromato- sis-associated tumours[J].Nat Rev Clin Oncol,2013,10(11):616-624.
  • 6Spyra M,Kluwe L,Hagel C,et al.Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors[J].PLoS One,2011,6(6):e21099.
  • 7Weiss B,Widemann BC,Wolters P,et al.Sirolimus for progressive neurofibromatosis type I-associated plexiform neurofibromas:a neuro- fibromatosis Clinical Trials Consortium phase II study[J].Neuro Oncol,2015,17(4):596-603.
  • 8Frahm S,Mautner VF,Brems H,et al.Genetic and phenotypic char- acterization of tumor cells derived from malignant peripheral nerve sheath tumors of neuro bromatosis type I patients[J].Neurobiol Dis,2004,16(1):85-91.
  • 9Lin AL,Gutmann DH.Advances in the treatment of neurofibromato- sis-associated tumours[J].Nat Rev Clin Oncol,2013,10(11):616-624.
  • 10Demestre M,Herzberg J,Holtkamp N,et al.Imatinib mesylate (Glivec)inhibits Schwann cell viability and reduces the size of hu- man plexiform neurofibroma in a xenograft model[J].J Neurooncol, 2010,98(1):11-19.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部